MERS vaccine is technically feasible, but is it commerically feasible?
Eva M
EM
Riedmann
D018352:Coronavirus Infections / Q000276:immunology / Q000517:prevention & control*; D055808:Drug Discovery / Q000191:economics*; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus / Q000276:immunology*; D014765:Viral Vaccines / Q000191:economics* / Q000302:isolation & purification*
D014765:Viral Vaccines